BiotechTubeBiotechTube
Home/Organogenesis/David C. Francisco
DC

David C. Francisco

Chief Financial Officer

Organogenesis

Therapeutic Areas

Advanced Wound CareSurgerySports Medicine

Organogenesis Pipeline

DrugIndicationPhase
Apligraf®Diabetic Foot Ulcers, Venous Leg UlcersApproved
Dermagraft®Diabetic Foot UlcersApproved
PuraPly®Various Wounds (surgical, traumatic, chronic)Approved
PuraPly® AMVarious Wounds with antimicrobial managementApproved

Leadership Team at Organogenesis

GS
Gary S. Gillheeney, Sr.
President, Chief Executive Officer and Chair of the Board
PB
Patrick Bilbo
Chief Operating Officer
BG
Brian Grow
Chief Commercial Officer
View full Organogenesis profile